Skip to main content
Equibles

PLATINUM INVESTMENT MANAGEMENT LTD

Position in PALI — Palisade Bio, Inc.

CIK 1256071 SYDNEY AUSTRALIA 2000, C3
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,617,509
+$1,462,535 QoQ
Shares Held
1,730,866
+40.6% QoQ
Ownership
0.993%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#31
of 124 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names. PALI ranks #9 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 58,314 $7,740,017
2 COGT
Cogent Biosciences, Inc.
 154,220 $5,968,314
3 IMVT
Immunovant, Inc.
 144,671 $5,574,173
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 64,752 $5,277,935
5 IDYA
IDEAYA Biosciences, Inc.
 138,708 $5,169,647
6 VERA
Vera Therapeutics, Inc.
 113,687 $4,878,309
7 GPCR
Structure Therapeutics Inc.
 90,363 $4,849,782
8 RCUS
Arcus Biosciences, Inc.
 134,217 $4,137,910

All Filings in PALI

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,617,509 1,730,866
2026-03-31 $2,154,974 1,231,414
2025-12-31 $1,560,604 664,087